Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer

NCT03360721 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped \<75% participation

Conditions

Castration-Resistant Prostate Carcinoma
Prostate Adenocarcinoma Without Neuroendocrine Differentiation
Stage IV Prostate Cancer AJCC v8
Stage IVA Prostate Cancer AJCC v8
Stage IVB Prostate Cancer AJCC v8

Interventions

DRUG: Abiraterone Acetate
DRUG: Apalutamide
DRUG: Prednisone

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]